Long-term release of fluocinolone acetonide using biodegradable fumarate-based polymers.

Intraocular drug delivery systems made from biodegradable polymers hold great potential to effectively treat chronic diseases of the posterior segment of the eye. This study is based on the hypothesis that crosslinked poly(propylene fumarate) (PPF)-based matrices are suitable long-term delivery devices for the sustained release of the anti-inflammatory drug fluocinolone acetonide (FA) due to their hydrophobicity and network density. FA-loaded rods of 10 mm length and 0.6 mm diameter were fabricated by photo-crosslinking PPF with N-vinyl pyrrolidone (NVP). The released amounts of FA and NVP were determined by HPLC analysis. The effects of drug loading and the ratio of PPF to NVP on the release kinetics were investigated using a 2(3-1) factorial design. Overall, FA release was sustained in vitro over almost 400 days by all tested formulations. Low burst release was followed by a dual modality release controlled by diffusion and bulk erosion with release rates up to 1.7 microg/day. The extent of the burst effect and the release kinetics were controlled by the drug loading and the matrix composition. Matrix water content and degradation were determined gravimetrically. Micro-computed tomography was used to image structural and dimensional changes of the devices. The results show that photo-crosslinked PPF-based matrices are promising long-term delivery devices for intraocular drug delivery.

[1]  Antonios G Mikos,et al.  In vitro degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds. , 2005, Biomaterials.

[2]  J. Fisher,et al.  Photocrosslinking characteristics and mechanical properties of diethyl fumarate/poly(propylene fumarate) biomaterials. , 2002, Biomaterials.

[3]  B. Khoobehi,et al.  Intravitreal liposome-encapsulated drugs: A preliminary human report , 2004, International Ophthalmology.

[4]  Peter Wiedemann,et al.  Drug delivery systems for vitreoretinal diseases , 2004, Progress in Retinal and Eye Research.

[5]  R. Adhikari,et al.  Biodegradable synthetic polymers for tissue engineering. , 2003, European cells & materials.

[6]  K. An,et al.  Mechanical properties of a biodegradable bone regeneration scaffold. , 2000, Journal of biomechanical engineering.

[7]  I. Constable,et al.  Crosslinked poly(1-vinyl-2-pyrrolidinone) as a vitreous substitute. , 1996, Journal of biomedical materials research.

[8]  Y. Ogura,et al.  Biodegradable Polymers for Ocular Drug Delivery , 2001, Ophthalmologica.

[9]  Y. Ogura,et al.  Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate. , 2003, Investigative ophthalmology & visual science.

[10]  P Rüegsegger,et al.  Micro-tomographic imaging for the nondestructive evaluation of trabecular bone architecture. , 1997, Studies in health technology and informatics.

[11]  N A Peppas,et al.  Highly crosslinked, PEG-containing copolymers for sustained solute delivery. , 1999, Biomaterials.

[12]  F. Hendrikse,et al.  New biodegradable networks of poly(N-vinylpyrrolidinone) designed for controlled nonburst degradation in the vitreous body. , 1999, Journal of biomedical materials research.

[13]  J. Fisher,et al.  Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model. , 2002, Journal of biomedical materials research.

[14]  G. Jaffe,et al.  Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device. , 2000, Investigative ophthalmology & visual science.

[15]  A. Mikos,et al.  In vivo degradation of a poly(propylene fumarate)/beta-tricalcium phosphate injectable composite scaffold. , 1998, Journal of biomedical materials research.

[16]  Matthew A. Thomas,et al.  The safety profile of long-term, high-dose intraocular corticosteroid delivery. , 2005, American journal of ophthalmology.

[17]  K. Küttler,et al.  Subchronic inhalation and oral toxicity of N-vinylpyrrolidone-2. Studies in rodents. , 1997, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[18]  Esther Eljarrat-Binstock,et al.  Iontophoresis: a non-invasive ocular drug delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[19]  J. Fisher,et al.  Photoinitiated cross-linking of the biodegradable polyester poly(propylene fumarate). Part II. In vitro degradation. , 2003, Biomacromolecules.

[20]  Antonios G Mikos,et al.  Fabrication of poly(propylene fumarate)-based orthopaedic implants by photo-crosslinking through transparent silicone molds. , 2003, Biomaterials.

[21]  Choll W. Kim,et al.  Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation. , 2004, Journal of biomedical materials research. Part A.

[22]  D. Wise,et al.  Analysis of a vinyl pyrrolidone/poly(propylene fumarate) resorbable bone cement. , 1995, Journal of biomedical materials research.

[23]  Y. Tabata,et al.  Biodegradable scleral plugs for vitreoretinal drug delivery. , 2001, Advanced drug delivery reviews.

[24]  X Huang,et al.  On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[25]  M J Yaszemski,et al.  Polymer concepts in tissue engineering. , 1998, Journal of biomedical materials research.

[26]  G. Peyman,et al.  Delivery systems for intraocular routes , 1995 .

[27]  J. Jansen,et al.  Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo. , 2005, Journal of biomedical materials research. Part A.

[28]  U. Pleyer,et al.  Corticosteroids in Ophthalmology: Past – Present – Future , 2002, Ophthalmologica.

[29]  A. Mikos,et al.  Synthesis of biodegradable poly(propylene fumarate) networks with poly(propylene fumarate)–diacrylate macromers as crosslinking agents and characterization of their degradation products , 2001 .

[30]  Jun Gao,et al.  Controlled drug release from hydrogel nanoparticle networks. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[31]  I. Grierson,et al.  Biomaterials used in the posterior segment of the eye. , 2000, Biomaterials.

[32]  David Dean,et al.  Photoinitiated cross-linking of the biodegradable polyester poly(propylene fumarate). Part I. Determination of network structure. , 2003, Biomacromolecules.

[33]  J. Cunha-Vaz.  The blood-retinal barriers system. Basic concepts and clinical evaluation. , 2004, Experimental eye research.

[34]  A. Mikos,et al.  Kinetics of poly(propylene fumarate) synthesis by step polymerization of diethyl fumarate and propylene glycol using zinc chloride as a catalyst , 2002, Journal of biomaterials science. Polymer edition.

[35]  G. Jaffe,et al.  Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. , 2005, Ophthalmology.

[36]  G. Jaffe,et al.  Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. , 2000, Ophthalmology.

[37]  J. Siepmann,et al.  Mathematical modeling of bioerodible, polymeric drug delivery systems. , 2001, Advanced drug delivery reviews.